ANDA 204962, held by Pharm Assoc. Prednisolone Sodium Phosphate.
As of Nov 16, 2026, ANDA 204962 (Prednisolone Sodium Phosphate), held by Pharm Assoc, was first approved by FDA on Mar 11, 2020, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 11, 2020 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisolone Sodium PhosphateEQ 30MG BASE/5ML · solution;oral | Prednisolone Sodium Phosphate | Discontinued |
| Jun 5, 2024 | Supplement 2Labeling · Standard review | Approved | None posted |
| Mar 11, 2020 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters